Epidemiology, Susceptibility, and Risk Factors Associated with Mortality in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Abdominal Solid Organ Transplant Recipients: A Retrospective Cohort Study

go back to reference Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16:18–18.CrossRef Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16:18–18.CrossRef

go back to reference Kohira N, West J, Ito A, Ito-Horiyama T, Nakamura R, Sato T, Rittenhouse S, Tsuji M, Yamano Y. In vitro antimicrobial activity of a siderophore cephalosporin, S-649266, against enterobacteriaceae clinical isolates, including carbapenem-resistant strains. Antimicrob Agents Chemother. 2016;60:729–34.CrossRef Kohira N, West J, Ito A, Ito-Horiyama T, Nakamura R, Sato T, Rittenhouse S, Tsuji M, Yamano Y. In vitro antimicrobial activity of a siderophore cephalosporin, S-649266, against enterobacteriaceae clinical isolates, including carbapenem-resistant strains. Antimicrob Agents Chemother. 2016;60:729–34.CrossRef

go back to reference Freire MP, Oshiro ICVS, Pierrotti LC, Bonazzi PR, de Oliveira LM, Song ATW, Camargo CH, van der Heijden IM, Rossi F, Costa SF, D’Albuquerque LAC, Abdala E. Carbapenem-resistant enterobacteriaceae acquired before liver transplantation. Transplantation. 2017;101:811–20.CrossRef Freire MP, Oshiro ICVS, Pierrotti LC, Bonazzi PR, de Oliveira LM, Song ATW, Camargo CH, van der Heijden IM, Rossi F, Costa SF, D’Albuquerque LAC, Abdala E. Carbapenem-resistant enterobacteriaceae acquired before liver transplantation. Transplantation. 2017;101:811–20.CrossRef

go back to reference Pereira MR, Scully BF, Pouch SM, Uhlemann A, Goudie S, Emond JE, Verna EC. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transplant. 2015;21:1511–9.CrossRef Pereira MR, Scully BF, Pouch SM, Uhlemann A, Goudie S, Emond JE, Verna EC. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transplant. 2015;21:1511–9.CrossRef

go back to reference Shields RK, Clancy CJ, Gillis LM, Kwak EJ, Silveira FP, Massih RC, Eschenauer GA, Potoski BA, Nguyen MH. Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients. PLoS ONE. 2012;7:e52349.CrossRef Shields RK, Clancy CJ, Gillis LM, Kwak EJ, Silveira FP, Massih RC, Eschenauer GA, Potoski BA, Nguyen MH. Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients. PLoS ONE. 2012;7:e52349.CrossRef

go back to reference Wan QQ, Ye QF, Yuan H. Multidrug-resistant Gram-negative bacteria in solid organ transplant recipients with bacteremias. Eur J Clin Microbiol Infect Dis. 2015;34:431–7.CrossRef Wan QQ, Ye QF, Yuan H. Multidrug-resistant Gram-negative bacteria in solid organ transplant recipients with bacteremias. Eur J Clin Microbiol Infect Dis. 2015;34:431–7.CrossRef

go back to reference Qiao B, Wu J, Wan Q, Zhang S, Ye Q. Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia. BMC Infect Dis. 2017;17:171.CrossRef Qiao B, Wu J, Wan Q, Zhang S, Ye Q. Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia. BMC Infect Dis. 2017;17:171.CrossRef

go back to reference Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.CrossRef Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.CrossRef

go back to reference Wolfe CR, Ison MG. Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13547.CrossRef Wolfe CR, Ison MG. Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13547.CrossRef

go back to reference Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M. Developing a new definition and assessing new clinical criteria for septic shock. JAMA. 2016;315:775.CrossRef Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M. Developing a new definition and assessing new clinical criteria for septic shock. JAMA. 2016;315:775.CrossRef

go back to reference Wu D, Chen C, Liu T, Wan Q. Risk factors for acquisition of carbapenem-resistant Klebsiella pneumoniae and mortality among abdominal solid organ transplant recipients with K. pneumoniae infections. Med Sci Monit. 2020;26:e922996.PubMedPubMedCentral Wu D, Chen C, Liu T, Wan Q. Risk factors for acquisition of carbapenem-resistant Klebsiella pneumoniae and mortality among abdominal solid organ transplant recipients with K. pneumoniae infections. Med Sci Monit. 2020;26:e922996.PubMedPubMedCentral

go back to reference Varotti G, Dodi F, Terulla A, Santori G, Mariottini G, Bertocchi M, Marchese A, Fontana I. Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation. Transpl Infect Dis. 2017;19:e12757.CrossRef Varotti G, Dodi F, Terulla A, Santori G, Mariottini G, Bertocchi M, Marchese A, Fontana I. Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation. Transpl Infect Dis. 2017;19:e12757.CrossRef

go back to reference Mouloudi E, Massa E, Papadopoulos S, Iosifidis E, Roilides I, Theodoridou T, Piperidou M, Orphanou A, Passakiotou M, Imvrios G, Fouzas I, Papanikolaou V, Gritsi-Gerogianni N. Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae among intensive care unit patients after orthotopic liver transplantation: risk factors for infection and impact of resistance on outcomes. Transpl Proc. 2014;46:3216–8.CrossRef Mouloudi E, Massa E, Papadopoulos S, Iosifidis E, Roilides I, Theodoridou T, Piperidou M, Orphanou A, Passakiotou M, Imvrios G, Fouzas I, Papanikolaou V, Gritsi-Gerogianni N. Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae among intensive care unit patients after orthotopic liver transplantation: risk factors for infection and impact of resistance on outcomes. Transpl Proc. 2014;46:3216–8.CrossRef

go back to reference Aguado JM, Silva JT, Fernández-Ruiz M, Cordero E, Fortún J, Gudiol C, Martínez-Martínez L, Vidal E, Almenar L, Almirante B, Cantón R, Carratalá J, Caston JJ, Cercenado E, Cervera C, Cisneros JM, Crespo-Leiro MG, Cuervas-Mons V, Elizalde-Fernández J, Fariñas MC, Gavaldà J, Goyanes MJ, Gutiérrez-Gutiérrez B, Hernández D, Len O, López-Andujar R, López-Medrano F, Martín-Dávila P, Montejo M, Moreno A, Oliver A, Pascual A, Pérez-Nadales E, Román-Broto A, San-Juan R, Serón D, Solé-Jover A, Valerio M, Muñoz P, Torre-Cisneros J. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. Transpl Rev. 2018;32:36–57.CrossRef Aguado JM, Silva JT, Fernández-Ruiz M, Cordero E, Fortún J, Gudiol C, Martínez-Martínez L, Vidal E, Almenar L, Almirante B, Cantón R, Carratalá J, Caston JJ, Cercenado E, Cervera C, Cisneros JM, Crespo-Leiro MG, Cuervas-Mons V, Elizalde-Fernández J, Fariñas MC, Gavaldà J, Goyanes MJ, Gutiérrez-Gutiérrez B, Hernández D, Len O, López-Andujar R, López-Medrano F, Martín-Dávila P, Montejo M, Moreno A, Oliver A, Pascual A, Pérez-Nadales E, Román-Broto A, San-Juan R, Serón D, Solé-Jover A, Valerio M, Muñoz P, Torre-Cisneros J. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. Transpl Rev. 2018;32:36–57.CrossRef

go back to reference Oriol I, Sabé N, Melilli E, Lladó L, González-Costello J, Soldevila L, Carratalà J. Factors influencing mortality in solid organ transplant recipients with bloodstream infection. Clin Microbiol Infect. 2015;21:1104.e9-1104.e14.CrossRef Oriol I, Sabé N, Melilli E, Lladó L, González-Costello J, Soldevila L, Carratalà J. Factors influencing mortality in solid organ transplant recipients with bloodstream infection. Clin Microbiol Infect. 2015;21:1104.e9-1104.e14.CrossRef

go back to reference Mazza E, Prosperi M, Panzeri MF, Limuti R, Nichelatti M, De Gasperi A. Carbapenem-resistant Klebsiella pneumoniae infections early after liver transplantation: a single-center experience. Transpl Proc. 2017;49:677–81.CrossRef Mazza E, Prosperi M, Panzeri MF, Limuti R, Nichelatti M, De Gasperi A. Carbapenem-resistant Klebsiella pneumoniae infections early after liver transplantation: a single-center experience. Transpl Proc. 2017;49:677–81.CrossRef

go back to reference Bodro M, Sabé N, Tubau F, Lladó L, Baliellas C, Roca J, Cruzado JM, Carratalà J. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transpl J. 2013;96:843–9.CrossRef Bodro M, Sabé N, Tubau F, Lladó L, Baliellas C, Roca J, Cruzado JM, Carratalà J. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transpl J. 2013;96:843–9.CrossRef

go back to reference Garnacho-Montero J, Gutierrez-Pizarraya A, Escoresca-Ortega A, Fernandez-Delgado E, Lopez-Sanchez JM. Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality. Crit Care. 2015;19:302.CrossRef Garnacho-Montero J, Gutierrez-Pizarraya A, Escoresca-Ortega A, Fernandez-Delgado E, Lopez-Sanchez JM. Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality. Crit Care. 2015;19:302.CrossRef

go back to reference Wan Q, Ye Q, Zhou J. Mortality predictors of bloodstream infections in solid-organ transplant recipients. Exp Clin Transpl. 2013;11:211–4.CrossRef Wan Q, Ye Q, Zhou J. Mortality predictors of bloodstream infections in solid-organ transplant recipients. Exp Clin Transpl. 2013;11:211–4.CrossRef

go back to reference Russwurm S, Vickers J, Meier-Hellmann A, Spangenberg P, Bredle D, Reinhart K, Losche W. Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock. 2002;17:263–8.CrossRef Russwurm S, Vickers J, Meier-Hellmann A, Spangenberg P, Bredle D, Reinhart K, Losche W. Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock. 2002;17:263–8.CrossRef

go back to reference Nellore A, Fishman JA. Donor-derived infections and infectious risk in xenotransplantation and allotransplantation. Xenotransplantation. 2018;25:e12423.CrossRef Nellore A, Fishman JA. Donor-derived infections and infectious risk in xenotransplantation and allotransplantation. Xenotransplantation. 2018;25:e12423.CrossRef

go back to reference Tong L, Hu X, Huang F, Huang S, Li L, Tang Z, Yao J, Xu J, Zhu Y, Chen Y, He X, Guan X, Cai C. Clinical impacts and outcomes with possible donor-derived infection in infected donor liver transplantation: a single-center retrospective study in China. J Infect Dis. 2020;221:S164–73.CrossRef Tong L, Hu X, Huang F, Huang S, Li L, Tang Z, Yao J, Xu J, Zhu Y, Chen Y, He X, Guan X, Cai C. Clinical impacts and outcomes with possible donor-derived infection in infected donor liver transplantation: a single-center retrospective study in China. J Infect Dis. 2020;221:S164–73.CrossRef

go back to reference Errico G, Gagliotti C, Monaco M, Masiero L, Gaibani P, Ambretti S, Landini MP, Arezzo SD, Di Caro A, Parisi SG, Palù G, Vespasiano F, Morsillo F, Moro ML, Procaccio F, Ricci A, Grossi PA, Pantosti A, Nanni Costa A, Farina C, Vailati F, Gesu G, Vismara C, Arghittu M, Colombo R, Torresani E, Rossi L, Conaldi PG, Gona F, Cambieri P, Marone P, Venditti C, Fernandez AG, Mancini C, Cusi M, De Angelis LH, Fossati L, Finarelli AC, De Cillia C, Sangiorgi G, Pinna AD, Stella F, Viale P, Colledan M, Platto M, Bonizzoli M, Peris A, Torelli R, Vesconi S, Cibelli E, De Carlis L, De Gasperi A, Ravini M, Carrinola R, Coluccio E, Dondossola D, Rossi G, Santambrogio L, Tosi D, Feltrin G, Rago C, Cillo U, Da Riva A, Rea F, Sparacino V, Bertani A, Canzonieri M, Gridelli B, Mularoni A, Spada M, Carrara E, Armini AMD, Paladini P, Adorno D, Valeri M, Caprio M, Di Ciaccio P, Puoti F, Berloco P, Auria BD, Maldarelli F, Paglialunga G, Pugliese F, Rossi M, Venuta F, Amoroso A, Giacometti R, Rinaldi M, Salizzoni M. Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy. Clin Microbiol Infect. 2019;25:203–9.CrossRef Errico G, Gagliotti C, Monaco M, Masiero L, Gaibani P, Ambretti S, Landini MP, Arezzo SD, Di Caro A, Parisi SG, Palù G, Vespasiano F, Morsillo F, Moro ML, Procaccio F, Ricci A, Grossi PA, Pantosti A, Nanni Costa A, Farina C, Vailati F, Gesu G, Vismara C, Arghittu M, Colombo R, Torresani E, Rossi L, Conaldi PG, Gona F, Cambieri P, Marone P, Venditti C, Fernandez AG, Mancini C, Cusi M, De Angelis LH, Fossati L, Finarelli AC, De Cillia C, Sangiorgi G, Pinna AD, Stella F, Viale P, Colledan M, Platto M, Bonizzoli M, Peris A, Torelli R, Vesconi S, Cibelli E, De Carlis L, De Gasperi A, Ravini M, Carrinola R, Coluccio E, Dondossola D, Rossi G, Santambrogio L, Tosi D, Feltrin G, Rago C, Cillo U, Da Riva A, Rea F, Sparacino V, Bertani A, Canzonieri M, Gridelli B, Mularoni A, Spada M, Carrara E, Armini AMD, Paladini P, Adorno D, Valeri M, Caprio M, Di Ciaccio P, Puoti F, Berloco P, Auria BD, Maldarelli F, Paglialunga G, Pugliese F, Rossi M, Venuta F, Amoroso A, Giacometti R, Rinaldi M, Salizzoni M. Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy. Clin Microbiol Infect. 2019;25:203–9.CrossRef

go back to reference Park Y, Choi Q, Kwon GC, Koo SH. Molecular epidemiology and mechanisms of tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae isolates. J Clin Lab Anal. 2020;34:e23506. PubMedPubMedCentral Park Y, Choi Q, Kwon GC, Koo SH. Molecular epidemiology and mechanisms of tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae isolates. J Clin Lab Anal. 2020;34:e23506. PubMedPubMedCentral

go back to reference Guan X, He L, Hu B, Hu J, Huang X, Lai G, Li Y, Liu Y, Ni Y, Qiu H, Shao Z, Shi Y, Wang M, Wang R, Wu D, Xie C, Xu Y, Yang F, Yu K, Yu Y, Zhang J, Zhuo C. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement. Clin Microbiol Infect. 2016;22:S15–25.CrossRef Guan X, He L, Hu B, Hu J, Huang X, Lai G, Li Y, Liu Y, Ni Y, Qiu H, Shao Z, Shi Y, Wang M, Wang R, Wu D, Xie C, Xu Y, Yang F, Yu K, Yu Y, Zhang J, Zhuo C. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement. Clin Microbiol Infect. 2016;22:S15–25.CrossRef

go back to reference McGovern PC, Wible M, El-Tahtawy A, Biswas P, Meyer RD. All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials. Int J Antimicrob Agents. 2013;41:463–7.CrossRef McGovern PC, Wible M, El-Tahtawy A, Biswas P, Meyer RD. All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials. Int J Antimicrob Agents. 2013;41:463–7.CrossRef

go back to reference Guner R, Hasanoglu I, Keske S, Kalem AK, Tasyaran MA. Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy. Infection. 2011;39:515–8.CrossRef Guner R, Hasanoglu I, Keske S, Kalem AK, Tasyaran MA. Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy. Infection. 2011;39:515–8.CrossRef

go back to reference El-Badawy MF, Abdelwahab SF, Alghamdi SA, Shohayeb MM. Characterization of phenotypic and genotypic traits of carbapenem-resistant Acinetobacter baumannii clinical isolates recovered from a tertiary care hospital in Taif, Saudi Arabia. Infect Drug Resist. 2019;12:3113–24.CrossRef El-Badawy MF, Abdelwahab SF, Alghamdi SA, Shohayeb MM. Characterization of phenotypic and genotypic traits of carbapenem-resistant Acinetobacter baumannii clinical isolates recovered from a tertiary care hospital in Taif, Saudi Arabia. Infect Drug Resist. 2019;12:3113–24.CrossRef

go back to reference Zeng L, Deng Q, Zeng T, Liu Y, Zhang J, Cao X. Prevalence of carbapenem-resistant Klebsiella pneumoniae infection in Southern China: clinical characteristics, antimicrobial resistance, virulence, and geographic distribution. Microbiol Drug Resist. 2020;26:483–91.CrossRef Zeng L, Deng Q, Zeng T, Liu Y, Zhang J, Cao X. Prevalence of carbapenem-resistant Klebsiella pneumoniae infection in Southern China: clinical characteristics, antimicrobial resistance, virulence, and geographic distribution. Microbiol Drug Resist. 2020;26:483–91.CrossRef

go back to reference Murri R, Fiori B, Spanu T, Mastrorosa I, Giovannenze F, Taccari F, Palazzolo C, Scoppettuolo G, Ventura G, Sanguinetti M, Cauda R, Fantoni M. Trimethoprim–sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series. Infection. 2017;45:209–13.CrossRef Murri R, Fiori B, Spanu T, Mastrorosa I, Giovannenze F, Taccari F, Palazzolo C, Scoppettuolo G, Ventura G, Sanguinetti M, Cauda R, Fantoni M. Trimethoprim–sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series. Infection. 2017;45:209–13.CrossRef

go back to reference Freire MP, Abdala E, Moura ML, de Paula FJ, Spadao F, Caiaffa-Filho HH, David-Neto E, Nahas WC, Pierrotti LC. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients. Infection. 2015;43:315–23.CrossRef Freire MP, Abdala E, Moura ML, de Paula FJ, Spadao F, Caiaffa-Filho HH, David-Neto E, Nahas WC, Pierrotti LC. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients. Infection. 2015;43:315–23.CrossRef

go back to reference Cai Y, Seah CL, Leck H, Lim T, Teo JQ, Lee W, Tan T, Koh T, Ee PLR, Kwa AL. Rapid antibiotic combination testing for carbapenem-resistant Gram-negative bacteria within six hours using ATP bioluminescence. Antimicrob Agents Chemother. 2018;62:1. CrossRef Cai Y, Seah CL, Leck H, Lim T, Teo JQ, Lee W, Tan T, Koh T, Ee PLR, Kwa AL. Rapid antibiotic combination testing for carbapenem-resistant Gram-negative bacteria within six hours using ATP bioluminescence. Antimicrob Agents Chemother. 2018;62:1. CrossRef

go back to reference Heldman MR, Guo K, Nelson B, Babu T, Ison MG. Treatment of multidrug‐resistant gram‐negative bacilli after solid organ transplant: outcomes and complications. Transpl Infect Dis. 2020:e13474. Heldman MR, Guo K, Nelson B, Babu T, Ison MG. Treatment of multidrug‐resistant gram‐negative bacilli after solid organ transplant: outcomes and complications. Transpl Infect Dis. 2020:e13474.

go back to reference Dan JM, Mendler MH, Hemming AW, Aslam S. High-dose tigecycline and colistin for successful treatment of disseminated carbapenem-resistant Klebsiella pneumoniae infection in a liver transplant recipient. Case Rep. 2014:bcr2014205865. Dan JM, Mendler MH, Hemming AW, Aslam S. High-dose tigecycline and colistin for successful treatment of disseminated carbapenem-resistant Klebsiella pneumoniae infection in a liver transplant recipient. Case Rep. 2014:bcr2014205865.

go back to reference Aoki T, Yoshizawa H, Yamawaki K, Yokoo K, Sato J, Hisakawa S, Hasegawa Y, Kusano H, Sano M, Sugimoto H, Nishitani Y, Sato T, Tsuji M, Nakamura R, Nishikawa T, Yamano Y. Cefiderocol (S-649266), a new siderophore cephalosporin exhibiting potent activities against Pseudomonas aeruginosa and other gram-negative pathogens including multi-drug resistant bacteria: structure activity relationship. Eur J Med Chem. 2018;155:847–68.CrossRef Aoki T, Yoshizawa H, Yamawaki K, Yokoo K, Sato J, Hisakawa S, Hasegawa Y, Kusano H, Sano M, Sugimoto H, Nishitani Y, Sato T, Tsuji M, Nakamura R, Nishikawa T, Yamano Y. Cefiderocol (S-649266), a new siderophore cephalosporin exhibiting potent activities against Pseudomonas aeruginosa and other gram-negative pathogens including multi-drug resistant bacteria: structure activity relationship. Eur J Med Chem. 2018;155:847–68.CrossRef

go back to reference van Duin D, Lok JJ, Earley M, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Fowler VJ, Paterson DL, Bonomo RA, Evans S. Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant enterobacteriaceae. Clin Infect Dis. 2018;66:163–71.CrossRef van Duin D, Lok JJ, Earley M, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Fowler VJ, Paterson DL, Bonomo RA, Evans S. Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant enterobacteriaceae. Clin Infect Dis. 2018;66:163–71.CrossRef

go back to reference Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, Brien RJO, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64:111–5.CrossRef Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, Brien RJO, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64:111–5.CrossRef